Cargando…

Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods

Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal-Martínez, Leticia, Herrera, Laura, Valero, Clara, de la Cruz, Paula, Ghimpu, Larisa, Mesa-Arango, Ana C., Santoni, Gabriela, Goterris, Lidia, Millán, Rosario, Buitrago, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145742/
https://www.ncbi.nlm.nih.gov/pubmed/33925404
http://dx.doi.org/10.3390/jof7050336
_version_ 1783697245248421888
author Bernal-Martínez, Leticia
Herrera, Laura
Valero, Clara
de la Cruz, Paula
Ghimpu, Larisa
Mesa-Arango, Ana C.
Santoni, Gabriela
Goterris, Lidia
Millán, Rosario
Buitrago, María José
author_facet Bernal-Martínez, Leticia
Herrera, Laura
Valero, Clara
de la Cruz, Paula
Ghimpu, Larisa
Mesa-Arango, Ana C.
Santoni, Gabriela
Goterris, Lidia
Millán, Rosario
Buitrago, María José
author_sort Bernal-Martínez, Leticia
collection PubMed
description Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis.
format Online
Article
Text
id pubmed-8145742
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81457422021-05-26 Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods Bernal-Martínez, Leticia Herrera, Laura Valero, Clara de la Cruz, Paula Ghimpu, Larisa Mesa-Arango, Ana C. Santoni, Gabriela Goterris, Lidia Millán, Rosario Buitrago, María José J Fungi (Basel) Article Opportunistic fungal pneumonias (OFP) are the main cause of death in AIDS patients worldwide. Diagnosis of these infections is often late as tuberculosis (TB) is frequently the first suspicion. In addition, diagnostic tools have limitations and are unavailable in disadvantaged regions. To perform the differential diagnosis of the main fungi causing OFP in AIDS patients (Histoplasma capsulatum, Cryptococcus neoformans/C. gattii and Pneumocystis jirovecii) vs. the Mycobacterium tuberculosis complex (MTBC), two new assays were developed: (i) a multiplex real-time PCR (MRT-PCR) and (ii) a simple and cost-effective method based on real-time PCR and the analysis of melting curves after amplification (MC-PCR). Both of the techniques were optimized and standardized “in vitro”, showing a suitable reproducibility (CV ranged between 1.84 and 3.81% and 1.41 and 4.83%, respectively), a 100% specificity and detection limits between 20 and 2 fg of genomic DNA per 20 µL of reaction. A validation study was performed by retrospectively using 42 clinical samples from 37 patients with proven fungal infection or TB, and 33 controls. The overall sensitivity for the MRT-PCR assay and the MC-PCR assay was 88% and 90.4%, respectively. Both techniques were fast, sensitive and reproducible, allowing for the detection of these pathogens and the performance of a differential diagnosis. MDPI 2021-04-27 /pmc/articles/PMC8145742/ /pubmed/33925404 http://dx.doi.org/10.3390/jof7050336 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bernal-Martínez, Leticia
Herrera, Laura
Valero, Clara
de la Cruz, Paula
Ghimpu, Larisa
Mesa-Arango, Ana C.
Santoni, Gabriela
Goterris, Lidia
Millán, Rosario
Buitrago, María José
Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title_full Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title_fullStr Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title_full_unstemmed Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title_short Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods
title_sort differential diagnosis of fungal pneumonias vs. tuberculosis in aids patients by using two new molecular methods
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145742/
https://www.ncbi.nlm.nih.gov/pubmed/33925404
http://dx.doi.org/10.3390/jof7050336
work_keys_str_mv AT bernalmartinezleticia differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT herreralaura differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT valeroclara differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT delacruzpaula differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT ghimpularisa differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT mesaarangoanac differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT santonigabriela differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT goterrislidia differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT millanrosario differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods
AT buitragomariajose differentialdiagnosisoffungalpneumoniasvstuberculosisinaidspatientsbyusingtwonewmolecularmethods